Zum Hauptinhalt springen

International Analgesia and Sedation Weaning and Withdrawal Practices in Critically Ill Adults: The Adult Iatrogenic Withdrawal Study in the ICU.

Bolesta, S ; Burry, L ; et al.
In: Critical care medicine, Jg. 51 (2023-11-01), Heft 11, S. 1502-1514
academicJournal

Titel:
International Analgesia and Sedation Weaning and Withdrawal Practices in Critically Ill Adults: The Adult Iatrogenic Withdrawal Study in the ICU.
Autor/in / Beteiligte Person: Bolesta, S ; Burry, L ; Perreault, MM ; Gélinas, C ; Smith, KE ; Eadie, R ; Carini, FC ; Saltarelli, K ; Mitchell, J ; Harpel, J ; Stewart, R ; Riker, RR ; Fraser, GL ; Erstad, BL
Zeitschrift: Critical care medicine, Jg. 51 (2023-11-01), Heft 11, S. 1502-1514
Veröffentlichung: Philadelphia, PA : Lippincott Williams & Wilkins ; <i>Original Publication</i>: New York, Kolen., 2023
Medientyp: academicJournal
ISSN: 1530-0293 (electronic)
DOI: 10.1097/CCM.0000000000005951
Schlagwort:
  • Child
  • Humans
  • Adult
  • Analgesics, Opioid adverse effects
  • Critical Illness therapy
  • Weaning
  • Intensive Care Units, Pediatric
  • Hypnotics and Sedatives adverse effects
  • Iatrogenic Disease epidemiology
  • Iatrogenic Disease prevention & control
  • Substance Withdrawal Syndrome epidemiology
  • Substance Withdrawal Syndrome drug therapy
  • Analgesia
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Corporate Authors: AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU) Study Investigators
  • Publication Type: Observational Study; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
  • Language: English
  • [Crit Care Med] 2023 Nov 01; Vol. 51 (11), pp. 1502-1514. <i>Date of Electronic Publication: </i>2023 Jun 07.
  • MeSH Terms: Substance Withdrawal Syndrome* / epidemiology ; Substance Withdrawal Syndrome* / drug therapy ; Analgesia* ; Child ; Humans ; Adult ; Analgesics, Opioid / adverse effects ; Critical Illness / therapy ; Weaning ; Intensive Care Units, Pediatric ; Hypnotics and Sedatives / adverse effects ; Iatrogenic Disease / epidemiology ; Iatrogenic Disease / prevention & control
  • Comments: Comment in: Crit Care Med. 2023 Nov 1;51(11):1600-1602. (PMID: 37902346)
  • References: Tobias JD: Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000; 28:2122–2132. ; Anand KJS, Willson DF, Berger J, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network: Tolerance and withdrawal from prolonged opioid use in critically III children. Pediatrics. 2010; 125:e1208–e1225. ; Wang PP, Huang E, Feng X, et al.: Opioid-associated iatrogenic withdrawal in critically ill adult patients: A multicenter prospective observational study. Ann Intensive Care. 2017; 7:88. ; Brown C, Albrecht R, Pettit H, et al.: Opioid and benzodiazepine withdrawal syndrome in adult burn patients. Am Surg. 2000; 66:367–370; discussion 370-1. ; Arroyo-Novoa CM, Figueroa-Ramos M, Puntillo K: 1614: Identifying opioid and benzodiazepine withdrawal in trauma intensive care unit (TICU) patients. Crit Care Med. 1614; 2018:791–791. ; Duceppe M-A, Perreault MM, Frenette AJ, et al.: Frequency, risk factors and symptomatology of iatrogenic withdrawal from opioids and benzodiazepines in critically ill neonates, children and adults: A systematic review of clinical studies. J Clin Pharm Ther. 2019; 44:148–156. ; Cammarano WB, Pittet JF, Weitz S, et al.: Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med. 1998; 26:676–684. ; Hyun D, Huh JW, Hong SB, et al.: Iatrogenic opioid withdrawal syndrome in critically ill patients: A retrospective cohort study. J Korean Med Sci. 2020; 35:1–12. ; Sanchez-Pinto LN, Nelson LP, Lieu P, et al.: Implementation of a risk-stratified opioid weaning protocol in a pediatric intensive care unit. J Crit Care. 2018; 43:214–219. ; Tiacharoen D, Lertbunrian R, Veawpanich J, et al.: Protocolized sedative weaning vs usual care in pediatric critically ill patients: A pilot randomized controlled trial. Indian J Crit Care Med. 2020; 24:451–458. ; Vyas D, Quinones Cardona V, Carroll A, et al.: Standardized scoring tool and weaning guideline to reduce opioids in critically ill neonates. Pediatr Qual Saf. 2022; 7:e562. ; Solodiuk JC, Greco CD, O’Donnell KA, et al.: Effect of a sedation weaning protocol on safety and medication use among hospitalized children post critical illness. J Pediatr Nurs. 2019; 49:18–23. ; Chiu AW, Contreras S, Mehta S, et al.: Iatrogenic opioid withdrawal in critically ill patients: A review of assessment tools and management. Ann Pharmacother. 2017; 51:1099–1111. ; von Elm E, Altman DG, Egger M, et al.; STROBE Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007; 370:1453–1457. ; Harris PA, Taylor R, Thielke R, et al.: Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42:377–381. ; Harris PA, Taylor R, Minor BL, et al.; REDCap Consortium: The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95:103208. ; Valentin A, Ferdinande P; ESICM Working Group on Quality Improvement: Recommendations on basic requirements for intensive care units: Structural and organizational aspects. Intensive Care Med. 2011; 37:1575–1587. ; Brilli RJ, Spevetz A, Branson RD, et al.; American College of Critical Care Medicine Task Force on Models of Critical Care Delivery. The American College of Critical Care Medicine Guidelines for the Definition of an Intensivist and the Practice of Critical Care Medicine: Critical care delivery in the intensive care unit: Defining clinical roles and the best practice model. Crit Care Med. 2001; 29:2007–2019. ; Iapichino G, Bertolini G, Pezzi A, et al.: Use of sedative and analgesic drugs in the first week of ICU stay in high-level-of-care. Minerva Anestesiol. 2003; 69:765771–770774. ; Gill KV, Voils SA, Chenault GA, et al.: Perceived versus actual sedation practices in adult intensive care unit patients receiving mechanical ventilation. Ann Pharmacother. 2012; 46:1331–1339. ; Devlin JW, Skrobik Y, Gélinas C, et al.: Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018; 46:E825–E873. ; Curley MAQ, Wypij D, Watson RS, et al.: Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: A randomized clinical trial. JAMA—J Am Med Assoc. 2015; 313:379–389. ; Amirnovin R, Sanchez-Pinto LN, Okuhara C, et al.: Implementation of a risk-stratified opioid and benzodiazepine weaning protocol in a pediatric cardiac ICU. Pediatr Crit Care Med. 2018; 19:1024–1032. ; Sneyers B, Duceppe MA, Frenette AJ, et al.: Strategies for the prevention and treatment of iatrogenic withdrawal from opioids and benzodiazepines in critically ill neonates, children and adults: A systematic review of clinical studies. Drugs. 2020; 80:1211–1233. ; Burry LD, Williamson DR, Perreault MM, et al.: Analgesic, sedative, antipsychotic, and neuromuscular blocker use in Canadian intensive care units: A prospective, multicentre, observational study. Can J Anesth. 2014; 61:619–630. ; Borkowska M, Labeau S, Schepens T, et al.: Nurses’ Sedation practices during weaning of adults from mechanical ventilation in an intensive care unit. Am J Crit Care. 2018; 27:32–42. ; Capilnean A, Martone A, Rosu VA, et al.: Validation of the withdrawal assessment tool-1 in adult intensive care patients. Am J Crit Care. 2019; 28:361–369. ; Tapaskar N, Colon Hidalgo D, Koo G, et al.: Sedation usage in COVID-19 acute respiratory distress syndrome: A multicenter study. Ann Pharmacother. 2022; 56:117–123. ; Dreucean D, Harris JE, Voore P, et al.: Approach to sedation and analgesia in COVID-19 patients on venovenous extracorporeal membrane oxygenation. Ann Pharmacother. 2022; 56:73–82. ; Balakrishna A, Walsh EC, Hamidi A, et al.: An examination of sedation requirements and practices for mechanically ventilated critically ill patients with COVID-19. Am J Heal Pharm. 2021; 78:1952–1961. ; Wongtangman K, Santer P, Wachtendorf LJ, et al.; SICU Optimal Mobilization Team (SOMT) Group: Association of sedation, coma, and in-hospital mortality in mechanically ventilated patients with coronavirus disease 2019-related acute respiratory distress syndrome: A retrospective cohort study*. Crit Care Med. 2021; 49:1524–1534. ; Flinspach AN, Booke H, Zacharowski K, et al.: High sedation needs of critically ill COVID-19 ARDS patients—a monocentric observational study. PLoS One. 2021; 16:e0253778.
  • Grant Information: P20 GM139745 United States GM NIGMS NIH HHS
  • Contributed Indexing: Investigator: S Alcántara, Hospital Universitario Puerta de Hierro Majadahonda.; N Aldardeer, King Faisal Specialist Hospital and Research Centre.; A Alhammad, King Saud University Medical City-King Khalid University Hospital.; S Almohaish, Virginia Commonwealth University.; M Ammar, Yale New Haven Hospital.; CM Arroyo-Novoa, Puerto Rico Trauma Hosptial.; DK Awassi, Hôpital Maisonneuve-Rosemont.; M Badano, Hospital Italiano La Plata.; B Badman, Princess Alexandra Hospital.; S Barnes, Manchester University NHS Foundation Trust.; M Bertozzi, Sanatorio Anchorena San Martin.; S Botros, Ninewells Hospital, NHS Tayside.; G Brophy, Virginia Commonwealth University.; C Brown, Mayo Clinic.; G Brown, St. Paul's Hospital.; M Buckley, Banner University Medical Center Phoenix.; S Burgess, Queen Elizabeth II Health Sciences Centre.; J Campbell, Guthrie Robert Packer Hospital.; C Carothers, Orlando Regional Center.; P Celario, Sanatorio 9 de Julio.; L Chambers, Vidant Medical Center.; G Chanques, CHU of Montpellier.; S Contreras; V d'Hebron, University Hospital.; J Cortes, Memorial Hermann-Texas Medical Center.; G Cozzi, Beth Israel Deaconess Medical Center.; M Cucci, Cleveland Clinic Akron General.; E Cunto, Hospital de Infecciosas F J Muñiz.; D Dao, Jewish General Hospital.; A Defayette, Roswell Park Comprehensive Cancer Center.; A Dey, Prince of Wales Hospital.; A Diaz, Hospital Misericordia Nuevo Siglo.; D Dixit, Rutgers University Hospital.; JN Dube, Centre hospitalier affilié universitaire régional de Trois-Rivières.; MA Duceppe, Royal Victoria Hospital- McGill University Health Centre.; A Dzierba, New York-Presbyterian Hospital.; O Farrell, University Hospital Plymouth NHSFT.; P Ferranti, Lister Hospital, Stevenage, East and North Herts NHS Trust.; A Flannery, University of Kentucky HealthCare.; G Fontaine, Intermountain Medical Center.; C Forehand, Augusta University Medical Center.; NF Nelson, Sanatorio del Oeste.; M Gillet, (CHU Liege, Be), Centre Hospitalier Universitaire de Liege.; GN Gonzalez, Hospital Italiano De Buenos Aires.; E Graham-Clarke, Sandwell and West Birmingham NHS Trust.; S Green, Royal North Shore Hospital.; C Groth, University of Rochester Medical Center.; H Hamid, AlMoalem Medical City.; L Hamilton, University of TN Medical Center.; J Hanley, Antrim Area Hospital.; J Jackson, Concord Repatriation General Hospital.; J Johnston, St. Joseph's University Medical Center.; S Kanji, Ottawa Hospital.; S Katzman, MercyOne Medical Center Des Moines.; M Kenes, University of Michigan.; J Kinney, Loma Linda University Health.; C Kohler, Royal Berkshire.; N Kovacic, WVU Medicine.; J Kuroski, Cleveland Clincial Marymount Hospital.; K Landolf, University of Maryland Medical Center.; R Laotheerachao, Keck Hospital of USC.; S Largana, (CHR Citadelle; Be), Centre Hospitalier Regional de la Citadelle.; G Lebrun, Centre hospitalier affilié universitaire régional de Trois-Rivières.; K Leonardo, Wye Valley NHS Trust.; E Levins, Oregon Health and Science University.; T Lewis-Wolfson, Valley Health Winchester Medical Center.; J Mailman, Saskatchewan Health Authority-Regina.; A Man, Mid and South Essex NHS Foundation Trust.; V Mandich, Hospital Santojanni.; I McCullagh, The Newcastle Hospital NHS.; J McDonald, Milton Keynes University Hospital NHS Foundation Trust.; AM Gil, Hospital Aeronautico Central.; WSW Ng, St Vincent's Hospital Sydney.; H Nguyen, Gosford Hospital.; M O'Hare, The Royal Wolverhampton NHS Trust.; JEO Saleh, Hospital Abel Ayerza.; C Oswald, Saint Alphonsus Regional Medical Center.; A Patanwala, Royal Prince Alfred Hospital.; JF Payen, Grenoble Alpes University Hospital.; B Phan, Riverside University Health System.; J Radosevich, Dignity Health.; T Reiter, Methodist Dallas Medical Center.; C Remmington, Guy's and St Thomas' Hospital.; V Reyes, Hospital San Cayetano.; R Roberts, Massachusetts General Hospital.; J Sagardia, Hospital Posadas.; J Sall, Sheffield Teaching Hospitals NHS Foundation Trust.; D Sanchez, Hospital El Cruce SAMIC.; B Shoulders, University of Florida.; B Sneyers, CHU Mont-Godinne.; Z Thiboutot, Centre hospitalier de l'Universite de Montreal.; M Thompson, University of Kentucky.; A Timmins, Victoria Hospital.; CF Tolosa, Hospital San Juan Bautista.; C Tolosa; S Junin, Buenos Aires.; VG Torres, Hospital Provincial del Centenario.; S Tran, Westmead Hospital.; TH Trinh, St George's University Hospitals NHS Foundation Trust.; S Tynan, Barking, Havering and Redbridge University Hospitals Trust.; L Vu, UC Irvine Health.; F Wilson, Leeds Teaching Hospitals NHS Trust.; A Cook, University of Kentucky HealthCare.; A Ciolek, NewYork-Presbyterian Hospital.; A Haines, Saskatchewan Health Authority.; A Rodriguez, Hospital de Infecciosas F J Muñiz.; A Cheung, Mount Sinai Hospital.; A Leong, Saskatchewan Health Authority.; AL Nisnik, Hospital Misericordia Nuevo Siglo.; AM Mancilla, Vall d'Hebron University Hospital.; B Rinehimer, Wilkes-Barre General Hospital.; B Sloan, Keck Hospital of USC.; B Bissell, University of Kentucky HealthCare.; C Kulilg, St. Joseph's University Medical Center.; C Coombe, Wilkes-Barre General Hospital.; C Dominguez, Hospital de Infecciosas F J Muñiz.; C Wampole, Maine Medical Center.; C Rodriguez de la Quintana, Hospital El Cruce SAMIC.; D Mulodjanov, Jewish General Hospital.; D Tsoller, Jewish General Hospital.; D Bowen, Westmead Hospital.; D Gagnon, Maine Medical Center.; D Purkayastha, Ottawa Hospital.; D Ali, University of Kentucky HealthCare.; E Saidahmed, AlMoalem Medical City.; E Lewandowski, URMC Strong Memorial.; E Schranz, URMC Highland Hospital.; E MacNeil, Queen Elizabeth II Health Sciences Centre.; F Hanks, Guy's and St Thomas' Hospital.; H Kassab, St. Joseph's University Medical Center.; H Brokmeier, Mayo Clinic.; J Kaur, The Royal Wolverhampton NHS Trust.; J Huntress, URMC Highland Hospital.; J Clark, URMC Strong Memorial.; J Falvey, URMC Strong Memorial.; J De Giacomo, Keck Hospital of USC.; J Smith, Royal Berkshire.; J Ibarzabal, Hospital Provincial del Centenario.; J Niland, Leeds Teaching Hospitals NHS Trust.; J Muir, NewYork-Presbyterian Hospital.; K Gosek, NewYork-Presbyterian Hospital.; K Maynard, URMC Strong Memorial.; K Kooda, Mayo Clinic, Rochester.; K Pandya, University of Kentucky HealthCare.; K Kaupp, Queen Elizabeth II Health Sciences Centre.; L Ebitt, University of Kentucky HealthCare.; L Bordon, Hospital San Juan Bautista.; L Chiscano, Vall d'Hebron University Hospital.; M Sosa, Vall d'Hebron University Hospital.; M Cosep, Keck Hospital of USC.; M Lobo, Hospital San Juan Bautista.; MF Monte, Hospital de Infecciosas F J Muñiz.; M Sandler, Virginia Commonwealth University.; MT Bastin, University of Kentucky HealthCare.; M Armahizer, University of Maryland Medical Center.; M Wang, Maine Medical Center.; M Eshaghian, Keck Hospital of USC.; M Rizwan, Mayo Clinic.; M Patel, NewYork-Presbyterian Hospital.; N Pistillo, Hospital El Cruce SAMIC.; N Harris, Royal North Shore Hospital.; P Torella, Vall d'Hebron University Hospital.; P Phongsamran, Keck Hospital of USC.; P Woo, Keck Hospital of USC.; R Garcia, Intermountain Medical Center.; RG Sabelli, Hospital de Infecciosas F J Muñiz.; R Grant, Methodist Dallas Medical Center.; S Delibert, URMC Strong Memorial.; S Parli, University of Kentucky HealthCare.; S Wilson, University of Maryland Medical Center.; SYA Yeung, University of Maryland Medical Center.; S Putruele, Hospital Posadas.; S Rappaport, URMC Strong Memorial.; S Welch, St Vincent's Hospital Sydney.; V Moitra, NewYork-Presbyterian Hospital.; V Chediack, Hospital de Infecciosas F J Muñiz Buenos Aires Argentina.
  • Molecular Sequence: ClinicalTrials.gov NCT04422808
  • Substance Nomenclature: 0 (Analgesics, Opioid) ; 0 (Hypnotics and Sedatives)
  • Entry Date(s): Date Created: 20230607 Date Completed: 20231031 Latest Revision: 20231101
  • Update Code: 20231215

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -